Holen Sie sich die Stockscreener-App
2.06
1.17%
-0.03
Schlusskurs vom Vortag:
$2.09
Offen:
$2.06
24-Stunden-Volumen:
1,632
Relative Volume:
0.13
Marktkapitalisierung:
$14.46M
Einnahmen:
$1.34M
Nettoeinkommen (Verlust:
$-13.49M
KGV:
-0.166
EPS:
-12.4093
Netto-Cashflow:
$-3.07M
1W Leistung:
-5.25%
1M Leistung:
-4.37%
6M Leistung:
-22.35%
1J Leistung:
-73.92%
1-Tages-Spanne:
$2.06
$2.06
1-Wochen-Bereich:
$2.06
$2.2699
52-Wochen-Spanne:
$1.75
$9.56
Vyome Holdings Inc Stock (HIND) Company Profile
Firmenname
Vyome Holdings Inc
Sektor
Branche
Telefon
949-429-6680
Adresse
1001 CALLE AMANECER, SAN CLEMENTE
Compare HIND vs VRTX, REGN, ARGX, MRNA, RVMD
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
HIND
Vyome Holdings Inc
|
2.06 | 14.67M | 1.34M | -13.49M | -3.07M | -12.41 |
VRTX
Vertex Pharmaceuticals Inc
|
522.11 | 134.06B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
803.76 | 83.43B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
1,004.25 | 63.00B | 4.16B | 1.29B | 734.26M | 19.58 |
MRNA
Moderna Inc
|
137.30 | 56.02B | 2.23B | -3.19B | -1.60B | -8.1462 |
RVMD
Revolution Medicines Inc
|
209.67 | 44.44B | 742.00K | -1.37B | -1.07B | -7.0731 |
Vyome Holdings Inc Aktie (HIND) Neueste Nachrichten
Vyome Holdings, Inc. (NASDAQ: HIND) Share Price, HIND Stock News, HIND Share Price & Updates - Kalkine
Price to earnings forward of Vyome Holdings, Inc. – GETTEX:H1O - TradingView
Vyome Holdings CFO Leonard Jerry Listed in Latest SEC Insider Filing - Kalkine Media
Vyome Holdings Appoints Consulting CFO Jerry Leonard - The Globe and Mail
Vyome Holdings, Inc. Appoints Jerry Leonard as Principal Financial Officer and Principal Accounting Officer, Effective September 1, 2026 - marketscreener.com
Vyome Holdings (HIND) advances VT-1953, carries no debt - stocktitan.net
Vyome's wound gel reduced bad odor and improved lesion pain in statistically significant Phase 2 data - Stock Titan
Vyome Reports $720,000 Second-Quarter Net Loss as VT-1953 Program Advances - Quiver Quantitative
Vyome (HIND) Move: Records a 1.77% Increase to $2.31 on the Day; the Near-Term Reference Band Stretches From $2.19 to $2.43 in the Current UpdateSuperTrend - vinanet.vn
HIND Q2 2026 Earnings: Narrower-than-Expected Loss Delivers 48.4% EPS BeatForward EPS Estimate - vinanet.vn
VYOME HOLDINGS ($HIND) Releases Q2 2026 Earnings - Quiver Quantitative
Vyome Holdings Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Vyome Holdings (HIND) Edges Lower: Stock Testing Support Near $2.11KAMA Signal - Vinanet
Vyome Holdings (HIND) posts higher H1 2026 loss as R&D spending grows - Stock Titan
Vyome Holdings, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.com
Vyome Holdings Ord Shs (HIND) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Vyome Holdings Inc expected to post a loss of 19 cents a shareEarnings Preview - TradingView
HIND Q1 2026 Earnings: Narrower-Than-Expected Loss Lifts SentimentEPS Surprise History - vinanet.vn
HIND Q2'26 Earnings: EPS estimate is (0.19) USD - TradingView
Vyome Holdings, Inc. Revenue Breakdown – NASDAQ:HIND - TradingView
Vyome Holdings (HIND) Slides 2.37%: Support and Resistance Levels in FocusSafe Entry Stocks - dars.gov.et
HIND|Vyome Holdings Ord Shs|Price:2.060|Chg%:-0.080 - TradingKey
HIND|Vyome Holdings Ord Shs|Price:1.990|Chg%:-0.010 - TradingKey
Vyome Holdings (HIND) Q1 2026 Earnings: Narrower-Than-Expected Loss Fails to Lift SharesWeak Earnings Momentum - vinanet.vn
HIND Q1 2026 Earnings: Narrower-Than-Expected Loss Signals Improved Cost DisciplineTech Earnings Analysis - vinanet.vn
Price to sales forward of Vyome Holdings, Inc. – NASDAQ:HIND - TradingView
HIND Q1 2026 Earnings: EPS Beat Estimates as Cost Management Drives SurpriseEarnings Analysis - vinanet.vn
Vyome Holdings Inc. (HIND) Q1 2026 Earnings: Narrower Loss Beats Expectations Amid Weak Revenue DisclosureCFO Commentary Report - dars.gov.et
HIND Q1 2026 Earnings: Positive EPS Surprise Fails to Lift Shares Amid Revenue Uncertainty - vinanet.vn
HIND Q1 2026 Earnings: EPS Beat Despite Negative Earnings; Stock Slips 2.68%Guidance Revision Trend - vinanet.vn
Vyome (HIND) Proxy Filing Summary - Quartr
Vyome Holdings (HIND) Edges Lower Amid Consolidation Near Key SupportUnusual Call Volume - vinanet.vn
Vyome (HIND) Proxy filing Summary - Quartr
Vyome (HIND) Q4 2025 earnings summary - Quartr
Vyome (HIND) Q3 2025 earnings summary - Quartr
Vyome Holdings Inc. (HIND) Q1 2026 Earnings: Narrowing Losses Boost Investor ConfidenceRevenue Beat Analysis - dars.gov.et
Vyome Holdings (HIND) Slides 3.2% as Shares Test Key Support ZoneValue ETF - dars.gov.et
HIND Q1 2026 Earnings: Surprise EPS Beat Amidst No Revenue, Stock DeclinesEarnings Season Outlook - po-news-eg.net
Price to book forward of Vyome Holdings, Inc. – NASDAQ:HIND - TradingView
Vyome Holdings Inc. (HIND) Q1 2026 Earnings: EPS Surprise Beats Street EstimatesEPS Consistency Score - dars.gov.et
HIND Q1 2026 Earnings: Narrower-than-Expected Loss Drives Stock HigherEPS Miss Report - DonanımHaber
Enterprise value to EBITDA forward of Vyome Holdings, Inc. – NASDAQ:HIND - TradingView
Vyome receives Chinese patent for acne treatment formulation - Investing.com
Vyome receives Chinese patent for acne treatment formulation By Investing.com - Investing.com Canada
Enterprise value to revenue forward of Vyome Holdings, Inc. – NASDAQ:HIND - TradingView
Number of shareholders of Vyome Holdings, Inc. – NASDAQ:HIND - TradingView
Vyome Holdings, Inc. Actuals & Estimates (NASDAQ:HIND) - TradingView
HIND Forecast — Price Target — Prediction for 2027 - TradingView
Vyome Holdings Inc. (HIND) Q1 2026 Earnings: Narrower-Than-Expected Loss Fails to Lift StockEPS Consistency Score - dars.gov.et
ReShape Lifesciences Stock Rocketed 37% Today – Here’s Why - MSN
HIND Q1 2026 Earnings: EPS Surprises Positive as Cost Control Takes Center StageAnalyst Earnings Estimate - newsline.com
Finanzdaten der Vyome Holdings Inc-Aktie (HIND)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.63%
3.49%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):